Skip to main content

Table 1 Overall baseline characteristics and pathological outcomes

From: Short-term outcomes after minimally invasive versus open pancreaticoduodenectomy in elderly patients: a propensity score-matched analysis

Variables MIPD (N = 26) OPD (N = 119) P-value
Age (years) 71.03 ± 8.8 64.40 ± 11.70 0.008
Male (Male) 16 (61.5%) 70 (58.8%) 0.490
ASA (n, %)    0.895
 I 0 (0%) 1 (0.8%)  
 II 10 (38.5%) 46 (38.7%)  
 III 16 (61.5%) 72 (60.5%)  
ECOG (n, %)    0.003
 0 19 (73.1%) 112 (94.1%)  
 1 5 (19.2%) 6 (5.0%)  
 2 2 (7.7%) 1 (0.8%)  
Pathology (n, %)    0.036
 Benign 1 (3.8%) 9 (7.6%)  
 Ampullary cancer 13 (50.0%) 25 (21.0%)  
 CBD cancer 4 (15.4%) 17 (19.3%)  
 PDAC 5 (19.2%) 40 (42.0%)  
 IPMN 2 (7.7%) 3 (2.5%)  
 PNET 0 (0%) 6 (5.0%)  
 Duodenal cancer 1 (3.8%) 3 (2.5%)  
Tumor size (cm ± SD) 2.68 ± 1.80 3.14 ± 1.33 0.231
Lymph node harvest (number ± SD) 14.23 ± 8.04 19.83 ± 9.71 0.004
Pre-op bile drain (n, %) 14 (53.8%) 70 (58.8%) 0.400
Abdominal surgery history (n, %) 5 (19.2%) 25 (21.0%) 0.539
Hypertension (n, %) 14 (53.8%) 50 (42.0%) 0.189
DM (n, %) 8 (30.8%) 26 (21.8%) 0.232
CAD (n, %) 1 (3.8%) 15 (12.6) 0.174
COPD (n, %) 1 (3.8%) 2 (1.7%) 0.450
CKD (n, %) 1 (3.8%) 10 (8.4%) 0.378
CCI (n, %)    0.062
 0 8 (30.8%) 63 (52.9%)  
 1 10 (38.5%) 36 (30.3%)  
 2 7 (26.9) 16 (13.4%)  
 3 0 (0%) 3 (2.5%)  
 4 0 (0%) 1 (0.8)  
 5 1 0 (0%)  
  1. Italic indicate statistic significance
  2. MIPD minimal invasive pancreatoduodenectomy, OPD open pancreatoduodenectomy, ASA score American Society of Anesthesiologists classification score, ECOG Eastern Cooperative Oncology Group, CBD Common bile duct, PDAC pancreatic ductal adenocarcinoma, IPMN intraductal papillary mucinous neoplasm, PNET pancreatic neuroendocrine tumor, DM Diabetes Mellitus, CKD chronic kidney disease, CCI Charlson comorbidity index